Analysis of the key themes driving private equity deal activity reveals that immuno-oncology accounted for 3 pharmaceutical deals announced in Q3 2023, worth a total value of $50.4m. The $32m investment by Andera Partners, BioNTech, IP Group, Kreos Capital Group, Quan Capital, Sofinnova Partners and Takeda Ventures in Crescendo Biologics was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes and the Private Equity deal activity are included in GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, immuno-oncology-related deal activity decreased by 40% in Q3 2023 compared with the previous quarter’s total of $83.3m and fell by 89% as compared to Q3 2022. Related deal volume decreased by 57% in Q3 2023 versus the previous quarter and was 50% lower than in Q3 2022.
The top-ranked financial advisors supporting these private equity deals in Q3 2023 were Bank of Montreal; ROTH Capital Partners; Xingyuan Zhitong with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these private equity deals in Q3 2023 were Cooley; Foley Hoag; Goodwin Procter with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q3 2023 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Buyouts and Direct Investments done by Private Equity firms.
